Science Explorer Back to mapMap
Discussion
Company · Hradec Králové · Czechia

Generi Biotech (Czechia)

generi-biotech.com/homepage-generi-biotechROR OpenAlex
Research works
14
▲ 97% vs 2018-21
Citations
280
20.5 per fractional work
Top-10% rate
15.3%
all institutions 10.0%
Open access
42%
world 40%
International
31%
world 18%
Generi Biotech (Czechia)

Not ranked overall: Generi Biotech (Czechia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Generi Biotech (Czechia) work in?

In all years, 39% of research at Generi Biotech (Czechia) is in Life Sciences, 33% in Health Sciences. Its largest fields are Medicine (32%), Biochemistry, Genetics and Molecular Biology (31%), Engineering (16%). It does 1.7× the world's share of Life Sciences.

Life Sciences: 5 fractional works · 39.3% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 31.5% of its workMolecular Biology: 3 fractional works · 25.3% of its workGenetics: 0 fractional works · 2.9% of its workCancer Research: 0 fractional works · 1.2% of its workCell Biology: 0 fractional works · 1.2% of its workClinical Biochemistry: 0 fractional works · 0.6% of its workEndocrinology: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 4.3% of its workPlant Science: 0 fractional works · 2.6% of its workGeneral Agricultural and Biological Sciences: 0 fractional works · 0.8% of its workInsect Science: 0 fractional works · 0.6% of its workAgronomy and Crop Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 0 fractional works · 3.0% of its workImmunology: 0 fractional works · 2.2% of its workMicrobiology: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 0.5% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.5% of its workHealth Sciences: 5 fractional works · 33.2% of its workMedicine: 4 fractional works · 31.8% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 4.9% of its workEpidemiology: 0 fractional works · 3.4% of its workOncology: 0 fractional works · 3.3% of its workNephrology: 0 fractional works · 3.1% of its workPharmacology: 0 fractional works · 2.6% of its workHepatology: 0 fractional works · 2.3% of its workSurgery: 0 fractional works · 2.0% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.4% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 1.2% of its workInfectious Diseases: 0 fractional works · 1.1% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.9% of its workGenetics: 0 fractional works · 0.7% of its workDermatology: 0 fractional works · 0.6% of its workNeurology: 0 fractional works · 0.6% of its workObstetrics and Gynecology: 0 fractional works · 0.6% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.6% of its workUrology: 0 fractional works · 0.5% of its workHematology: 0 fractional works · 0.4% of its workPathology and Forensic Medicine: 0 fractional works · 0.3% of its workReproductive Medicine: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 1.2% of its workNutrition and Dietetics: 0 fractional works · 1.2% of its workHealth Professions: 0 fractional works · 0.2% of its workEmergency Medical Services: 0 fractional works · 0.2% of its workPhysical Sciences: 4 fractional works · 27.5% of its workEngineering: 2 fractional works · 15.7% of its workBiomedical Engineering: 2 fractional works · 11.3% of its workElectrical and Electronic Engineering: 0 fractional works · 2.4% of its workComputational Mechanics: 0 fractional works · 1.2% of its workOcean Engineering: 0 fractional works · 0.8% of its workChemistry: 1 fractional works · 6.1% of its workSpectroscopy: 1 fractional works · 6.1% of its workMaterials Science: 0 fractional works · 3.4% of its workMaterials Chemistry: 0 fractional works · 2.9% of its workBiomaterials: 0 fractional works · 0.5% of its workEnvironmental Science: 0 fractional works · 1.6% of its workWater Science and Technology: 0 fractional works · 1.2% of its workEcology: 0 fractional works · 0.4% of its workPhysics and Astronomy: 0 fractional works · 0.4% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.4% of its workEarth and Planetary Sciences: 0 fractional works · 0.3% of its workOceanography: 0 fractional works · 0.3% of its workALL ITS WORKGeneri Biotech(Czechia)14fractional works, all years
Life Sciences39%Physical Sciences27%Health Sciences33%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 13 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology431.5%
    2. Agricultural and Biological Sciences14.3%
    3. Immunology and Microbiology03.0%
    4. Neuroscience00.5%
    1. Medicine431.8%
    2. Nursing01.2%
    3. Health Professions00.2%
    1. Engineering215.7%
    2. Chemistry16.1%
    3. Materials Science03.4%
    4. Environmental Science01.6%
    5. Physics and Astronomy00.4%
    6. Earth and Planetary Sciences00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 3.90× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.66× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 6.78× its world share, 0 worksImmunology and Micro…Engineering: 1.34× its world share, 0 worksEngineeringEnvironmental Science: 0.09× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.75× its world share, 0 worksMaterials ScienceMedicine: 1.38× its world share, 1 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.8×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Immunology and Microbiology6.78×0 works
  2. Biochemistry, Genetics and Molecular Biology4.66×1 works
  3. Agricultural and Biological Sciences3.90×0 works
  4. Medicine1.38×1 works
  5. Engineering1.34×0 works
  6. Materials Science0.75×0 works
  7. Environmental Science0.09×0 works

Who are the top researchers at Generi Biotech (Czechia)?

Ranked on the quality score, A Paytuvi-Gallart, Martin Bunček and Riccardo Aiese Cigliano lead among researchers whose main affiliation is Generi Biotech (Czechia).

  1. 1 A Paytuvi-Gallart Czechia · #2,896,159 worldwide 0 citations · 16 works
  2. 2 Martin Bunček Czechia · #3,679,393 worldwide 461 citations · 18 works
  3. 3 Riccardo Aiese Cigliano Czechia · #5,163,452 worldwide 0 citations · 27 works
All ranked researchers at Generi Biotech (Czechia)

What are the most cited papers from Generi Biotech (Czechia)?

The most cited paper from Generi Biotech (Czechia) is "Proposal of a new thraustochytrid genus Hondaea gen. nov. and comparison of its lipid dynamics with the closely related pseudo-cryptic genus Aurantiochytrium" (Younès Dellero, Olivier Cagnac, Suzanne L. Rose et al., 2018), with 96 citations. Next come "Hydroxymethyl methacrylate-based monolithic columns designed for separation of oligonucleotides in hydrophilic-interaction capillary liquid chromatography" (81) and "Imaging of transfection and intracellular release of intact, non-labeled DNA using fluorescent nanodiamonds" (77).

Most cited papers
#PaperReleasedCitations
1 Proposal of a new thraustochytrid genus Hondaea gen. nov. and comparison of its lipid dynamics with the closely related pseudo-cryptic genus Aurantiochytrium Younès Dellero, Olivier Cagnac, Suzanne L. Rose et al. · Algal Research 31 Aug 2018 96
2 Hydroxymethyl methacrylate-based monolithic columns designed for separation of oligonucleotides in hydrophilic-interaction capillary liquid chromatography Petra Holdšvendová, Jana Suchánková, Martin Bunček et al. · Journal of Biochemical and Biophysical Methods 14 Nov 2006 81
3 Imaging of transfection and intracellular release of intact, non-labeled DNA using fluorescent nanodiamonds Vladimíra Petráková, Veronika Benson, Martin Bunček et al. · Nanoscale Open access 2016 77
4 New antituberculotics originated from salicylanilides with promising in vitro activity against atypical mycobacterial strains Aleš Imramovský, Jarmila Vinšová, Juana Monreal Férriz et al. · Bioorganic & Medicinal Chemistry 13 Apr 2009 49
5 In Vitro Transfection Mediated by Dendrigraft Poly( L ‐lysines): The Effect of Structure and Molecule Size Jakub Hofman, Martin Bunček, Radovan Haluza et al. · Macromolecular Bioscience 11 Dec 2012 46
All 52 most cited papers, with filters and sorting

Which research topics does Generi Biotech (Czechia) publish most on?

By volume in 2022-now: Postharvest Quality and Shelf Life Management, Extracellular vesicles in disease, Pancreatic function and diabetes and Genetically Modified Organisms Research.

Postharvest Quality and …0Postharvest Quality and Shelf Life Management: 0 fractional worksExtracellular vesicles in disease: 0 fractional worksPancreatic function and diabetes: 0 fractional worksGenetically Modified Organisms Research: 0 fractional worksParticle Dynamics in Fluid Flows: 0 fractional worksCyclone Separators and Fluid Dynamics: 0 fractional worksAdvanced biosensing and …0Advanced biosensing and bioanalysis techniques: 0 fractional worksDiet, Metabolism, and Disease: 0 fractional worksDNA and Nucleic Acid Chemistry: 0 fractional worksCancer therapeutics and …0Cancer therapeutics and mechanisms: 0 fractional works
Plant ScienceMolecular BiologySurgeryOcean Engineering2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Postharvest Quality and Shelf Life Management Plant Science 0 works
  2. 2 Extracellular vesicles in disease Molecular Biology 0 works
  3. 3 Pancreatic function and diabetes Surgery 0 works
  4. 4 Genetically Modified Organisms Research Plant Science 0 works
  5. 5 Particle Dynamics in Fluid Flows Ocean Engineering 0 works
  6. 6 Cyclone Separators and Fluid Dynamics Computational Mechanics 0 works
  7. 7 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
  8. 8 Diet, Metabolism, and Disease Endocrinology, Diabetes and Metabolism 0 works
  9. 9 DNA and Nucleic Acid Chemistry Molecular Biology 0 works
  10. 10 Cancer therapeutics and mechanisms Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.3%not open57.7%

World: 40% of research is openly available.

with international co-authors30.6%domestic only69.4%

World: 18% is written across borders.

How has Generi Biotech (Czechia)'s research output changed?

Output in 2022-2025 was 97% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Generi Biotech (Czechia) as a percentage of every work published that year, 0.000015% in 2024.

still counting0.000050%0.00010%0.00015%Generi Biotech (Czechia)0.0000082% in 202520102020

Fractional works of Generi Biotech (Czechia) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Hradec Králové

All research institutions in Hradec Králové

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Generi Biotech (Czechia). Posts are plain text and can be reported.